News | PRP Injections Improve Ovarian Reserve in a Mouse Model
A study in Aging, listed in MEDLINE/PubMed as Aging (Albany NY), found that intraovarian platelet-rich plasma (PRP) injections improved embryo quantity and quality in mice with chemotherapy-induced diminished ovarian reserve. The findings may offer a new treatment direction for women with premature ovarian aging or diminished ovarian reserve.
Ovarian aging gradually reduces egg quantity and quality and affects fertility. As childbearing is delayed, more patients face poor ovarian response (POR) or primary ovarian insufficiency (POI). PRP injection is an emerging approach showing potentially positive effects.
The study was conducted by scientists including Mauro Cozzolino, Yagmur Ergun, Denis A. Seli, and Sonia Herraiz of the IVIRMA Global Research Alliance. Researchers induced POR and POI in CD1 mice with high-dose chemotherapy, then administered PRP or sham injections.
PRP significantly improved the number and quality of blastocysts formed by mice with chemotherapy-related ovarian damage. The team also analyzed PRP proteins and assessed reproductive effects in multiple mouse strains.
The authors stated, "Taken together, our findings suggest that local PRP injection may positively affect blastocyst formation and quality." The findings may support further clinical research.
News | PRP Injections Improve Ovarian Reserve in a Mouse Model
News | PRP Injections Improve Ovarian Reserve in a Mouse Model
A study in Aging, listed in MEDLINE/PubMed as Aging (Albany NY), found that intraovarian platelet-rich plasma (PRP) injections improved embryo quantity and quality in mice with chemotherapy-induced diminished ovarian reserve. The findings may offer a new treatment direction for women with premature ovarian aging or diminished ovarian reserve.
Ovarian aging gradually reduces egg quantity and quality and affects fertility. As childbearing is delayed, more patients face poor ovarian response (POR) or primary ovarian insufficiency (POI). PRP injection is an emerging approach showing potentially positive effects.
The study was conducted by scientists including Mauro Cozzolino, Yagmur Ergun, Denis A. Seli, and Sonia Herraiz of the IVIRMA Global Research Alliance. Researchers induced POR and POI in CD1 mice with high-dose chemotherapy, then administered PRP or sham injections.
PRP significantly improved the number and quality of blastocysts formed by mice with chemotherapy-related ovarian damage. The team also analyzed PRP proteins and assessed reproductive effects in multiple mouse strains.
The authors stated, "Taken together, our findings suggest that local PRP injection may positively affect blastocyst formation and quality." The findings may support further clinical research.
Story source:
Collected online